News

Almirall and Forest said that Aclidinium was well tolerated in the study and all secondary endpoints demonstrated differences vs placebo for both doses. The Phase III double-blind placebo-controlled

Health Insights’ MedicaPlus is one of the comprehensive Hospital Information Management System applications to be developed in the Middle East. Health Insights’ decision to partner with InterSystems follows

The rejection of this patent application by The Indian Patent Office was for a combination of existing drugs and techniques. Following this decision, India can now supply this

VX15/2503 is a humanized antibody that blocks the activity of semaphorin 4D (SEMA4D). Vaccinex plans to initiate a second trial of VX15/2503 for MS later this year. Vaccinex

The new patent entitled, ‘Inhibitors of Serine Protease Activity and Their Use in Methods and Compositions for Treatment of Bacterial Infections,’ covers inhibition of all forms of Bacillus

ISIS-EIF4ERx targets the gene that is responsible for the production of a protein, eIF-4E, which is over-expressed in a variety of cancers, including prostate, lung, ovarian, liver, breast,

The recommended oral dose of Intelence tablets is 200 mg (one 200mg tablet or two 100mg tablets) taken twice daily after a meal. This new 200mg product formulation

Fusilev, a novel folate analog, is available in vials as freeze-dried powder. Fusilev is also indicated to diminish the toxicity and counteract the effects of impaired methotrexate elimination

Kiadis Pharma claims that ATIR will enable a mismatched family member to act as donor and is being developed to reduce transplant related mortality caused by infections and